Fresh Deals on W-Street: Special Research on Hospira, BT Group, Actavis, Ball, and Frontier

NEW YORK, February 6, 2015 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including Hospira (NYSE: HSP), BT Group (NYSE: BT), Actavis (NYSE: ACT), Ball (NYSE: BLL), and Frontier (NASDAQ: FTR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

HSP Research Report: ( http://get.analystsreview.com/pdf/?c=Hospira&d=06-Feb-2015&s=HSP ),

BT Research Report: ( http://get.analystsreview.com/pdf/?c=BT%20Group&d=06-Feb-2015&s=BT ),

ACT Research Report: ( http://get.analystsreview.com/pdf/?c=Actavis&d=06-Feb-2015&s=ACT ),

BLL Research Report: ( http://get.analystsreview.com/pdf/?c=Ball&d=06-Feb-2015&s=BLL ),

FTR Research Report: ( http://get.analystsreview.com/pdf/?c=Frontier&d=06-Feb-2015&s=FTR ).

============

--

Analyst Update: Mergers and Acquisitions

Reviewed by: Rohit Tuli, CFA®  

The U.S. stocks witnessed solid gains on Thursday as a rebound in the oil prices sparked rally in the energy shares, while the news of a big-ticket acquisition in the pharmaceutical sector boosted health-care stocks. Investors also shrugged off the mixed set of economic data. While weekly jobless claims rose less than expected last week, another data showed that nonfarm productivity fell more than expected in the fourth quarter. While the Dow Jones Industrial Average rose 1.20% to close at 17,884.88, the S&P 500 and the Nasdaq Composite gained 1.03% each to close at 2,062.52 and 4,765.10, respectively. In Europe, markets mostly ended higher in an otherwise choppy session as investors remained cautious amid Greece's struggle to renegotiate its bailout terms with the lenders. Concerns over Greece also weighed upon sentiments in Asian markets on Wednesday. Most Asian markets were down as European Central Bank said that it would no longer accept junk-rated Greece government debt as collateral for loans.

Hospira Inc. (Hospira) has agreed to be acquired by pharmaceutical giant Pfizer, Inc. (Pfizer) in a transaction valued at approx. $17 billion. The acquisition is expected to boost Pfizer's Global Established Pharmaceutical (GEP) business and be immediately accretive upon closing. Shares of Hospira jumped 35.25% on Thursday, hitting new 52-week high, after the deal. Continue reading about the latest merger in the healthcare space in our exclusive research report on Hospira.

BT Group Plc (BT Group) has reached a definitive agreement to acquire Britain's largest mobile phone operator EE Limited (EE) for £12.5 billion to create the UK's leading communications company. The deal, which combines the UK's most extensive broadband network with the country's most-advanced 4G mobile system, was welcomed by the investors as BT Group's ADRs jumped 6.06% on Thursday. Read more about the BT Group-EE deal in our exclusive research report.

Actavis plc (Actavis) has entered into an agreement to divest rights to branded respiratory business in the U.S. and Canada to AstraZeneca for an initial consideration of $600 million plus royalties in low single-digits. To know more about the Actavis' divestment agreement with AstraZeneca, please read our exclusive research report.

Shares of the drinks can maker Ball Corporation (Ball) jumped nearly 9% on Thursday after the Company confirmed that it was in talks concerning a possible acquisition of UK-based Rexam PLC (Rexam) in a cash-and-stock transaction. While Ball didn't provide further more details about the possible transaction, Rexam said that the proposal it has received from Ball values it at 610 pence per share. Continue reading about Ball's acquisition proposal for Rexam and its fourth quarter performance in our research report.

Frontier Communications Corp. (Frontier) announced that it has agreed to acquire Verizon's wireline operations in California, Florida and Texas, for $10.54 billion in cash. The acquired properties from Verizon include 3.7 million voice connections, 2.2 million broadband connections, and 1.2 million FiOS® video connections. To know more about the Frontier's acquisition agreement, please read our exclusive research report.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED